GlassScriptPhysician profile
Edward V Platia
NPI 1114963147
$4,603.46
in general payments reported to CMS, 2019-2025
12 companies · $961 in 2025
The $961 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $879 · 2020: $731 · 2021: $181 · 2022: $441 · 2023: $924 · 2024: $487 · 2025: $961.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,368 · Travel and Lodging: $3.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,368.17 |
| Travel and Lodging | $3.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $1,150.00 | 2019-2020 | |
| Abbott Laboratories | $1,012.54 | 2019-2025 | Ensite, Aveir |
| Medtronic, INC. | $814.62 | 2022-2025 | Cobalt Dr Mri Surescan, Micra |
| Boston Scientific Corporation | $640.87 | 2022-2025 | Clinical Trial Product, Farawave, General - Therapies |
| Atricure, INC. | $307.62 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Impulse Dynamics (USA) INC. | $180.93 | 2023-2025 | Optimizer, Optimizer |
| Biosense Webster, INC. | $149.44 | 2022-2023 | Carto 3 |
| Medtronic Vascular, INC. | $140.66 | 2019 | |
| Janssen Pharmaceuticals, INC | $117.46 | 2019-2021 | |
| Novo Nordisk INC | $39.21 | 2022 | |
| Kestra Medical Technology Services, INC. | $38.38 | 2025 | Assure Wcd |
| Philips North America LLC | $11.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Platia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.